Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
8.95
+0.01 (0.11%)
At close: Oct 2, 2026, 4:00 PM EDT
9.03
+0.08 (0.84%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Capricor Therapeutics Market Cap
Capricor Therapeutics has a market cap or net worth of $520.34 million as of October 2, 2026. Its market cap has increased by 45.55% in one year.
Market Cap
520.34M
Enterprise Value
373.45M
1-Year Change
45.55%
Ranking
Category
Stock Price
$8.95
ChartMarket Cap Chart
Since May 13, 2008, Capricor Therapeutics's market cap has increased from $130.10M to $520.34M, an increase of 299.96%. That is a compound annual growth rate of 7.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 520.30M | -60.57% |
| Dec 31, 2025 | 1.32B | 110.26% |
| Dec 31, 2024 | 627.50M | 316.67% |
| Dec 29, 2023 | 150.60M | 54.62% |
| Dec 30, 2022 | 97.40M | 37.57% |
| Dec 31, 2021 | 70.80M | 1.00% |
| Dec 31, 2020 | 70.10M | 1,198.15% |
| Dec 31, 2019 | 5.40M | -57.48% |
| Dec 31, 2018 | 12.70M | -68.72% |
| Dec 29, 2017 | 40.60M | -28.65% |
| Dec 30, 2016 | 56.90M | 13.80% |
| Dec 31, 2015 | 50.00M | 13.90% |
| Dec 31, 2014 | 43.90M | 1,467.86% |
| Dec 31, 2013 | 2.80M | 27.27% |
| Dec 31, 2012 | 2.20M | -89.91% |
| Dec 30, 2011 | 21.80M | 1.40% |
| Dec 31, 2010 | 21.50M | -36.39% |
| Dec 31, 2009 | 33.80M | 38.52% |
| Dec 31, 2008 | 24.40M | -81.25% |
| May 13, 2008 | 130.10M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 540.77M |
| Altimmune | 536.87M |
| MapLight Therapeutics | 535.19M |
| Allogene Therapeutics | 532.06M |
| Prime Medicine | 531.93M |
| Neurogene | 531.30M |
| Monopar Therapeutics | 523.35M |
| Eupraxia Pharmaceuticals | 517.54M |